Quarterly report · Q2

Period2023-09-01 → 2024-02-29
Filed2024-04-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥14.5bn2023-09-01 → 2024-02-29Cons.Net sales
Revenue¥25.6bn2022-09-01 → 2023-08-31Cons.Net sales (5-year summary)
Revenue¥12.4bn2022-09-01 → 2023-02-28Cons.Net sales
Operating income¥1.0bn2023-09-01 → 2024-02-29Cons.Operating income
Operating income¥678m2022-09-01 → 2023-02-28Cons.Operating income
Ordinary income¥1.1bn2023-09-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.1bn2023-09-01 → 2024-02-29Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.7bn2022-09-01 → 2023-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥708m2022-09-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥1.0bn2023-09-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥616m2022-09-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥642m2023-09-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.1bn2022-09-01 → 2023-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥414m2022-09-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥642m2023-09-01 → 2024-02-29Cons.Profit loss
Net income¥417m2022-09-01 → 2023-02-28Cons.Profit loss
Total assets¥44.3bnat 2024-02-29Cons.Assets
Total assets¥41.1bnat 2023-08-31Cons.Assets
Total assets¥39.0bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥30.7bnat 2024-02-29Cons.Liabilities
Total liabilities¥27.9bnat 2023-08-31Cons.Liabilities
Net assets / equity¥13.6bnat 2024-02-29Cons.Net assets
Net assets / equity¥13.2bnat 2023-08-31Cons.Net assets
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥10.3bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥11.2bnat 2023-08-31Cons.Cash and deposits
Cash & equivalents¥10.2bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥11.1bnat 2023-08-31Cons.Cash and cash equivalents
Cash & equivalents¥10.8bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2022-08-31dCons.Cash and cash equivalents
Operating cash flow−¥265m2023-09-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥865m2022-09-01 → 2023-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥397m2022-09-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥791m2022-09-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Financing cash flow¥708m2023-09-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow¥1.9bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥924m2022-09-01 → 2023-02-28Cons.Net cash provided by used in financing activities
EPS (basic)¥45.792023-09-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.992023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.512022-09-01 → 2023-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.462022-09-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.012022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥45.742023-09-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥78.462022-09-01 → 2023-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥29.452022-09-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio30.7%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio31.9%at 2023-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.3%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 45
SegmentItemPeriodValue
Otherother segmentsrevenue2023-09-01 → 2024-02-29¥1.0bn
Otherother segmentsrevenue external2023-09-01 → 2024-02-29¥1.0bn
Otherother segmentsrevenue intersegment2023-09-01 → 2024-02-29¥10m
Otherother segmentssegment profit2023-09-01 → 2024-02-29−¥167m
Reconciling Itemsreconcilingrevenue2023-09-01 → 2024-02-29−¥54m
Reconciling Itemsreconcilingrevenue intersegment2023-09-01 → 2024-02-29−¥54m
Reconciling Itemsreconcilingsegment profit2023-09-01 → 2024-02-29−¥335m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2023-09-01 → 2024-02-29¥2.6bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2023-09-01 → 2024-02-29¥2.6bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥2m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2023-09-01 → 2024-02-29¥41m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥5m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2023-09-01 → 2024-02-29−¥2m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2023-09-01 → 2024-02-29¥8.8bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2023-09-01 → 2024-02-29¥8.8bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥36m
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2023-09-01 → 2024-02-29¥1.4bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2023-09-01 → 2024-02-29¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2023-09-01 → 2024-02-29¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2023-09-01 → 2024-02-29¥86m
Total Of Reportable Segments And Otherssegment totalrevenue2023-09-01 → 2024-02-29¥14.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-09-01 → 2024-02-29¥14.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-09-01 → 2024-02-29¥54m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-09-01 → 2024-02-29¥1.4bn
Otherother segmentsrevenue2022-09-01 → 2023-02-28¥540m
Otherother segmentsrevenue external2022-09-01 → 2023-02-28¥540m
Otherother segmentssegment profit2022-09-01 → 2023-02-28−¥2m
Reconciling Itemsreconcilingsegment profit2022-09-01 → 2023-02-28−¥255m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2022-09-01 → 2023-02-28¥13m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2022-09-01 → 2023-02-28−¥121m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2022-09-01 → 2023-02-28¥940m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2022-09-01 → 2023-02-28¥103m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2023-02-28¥933m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Net increase decrease in short term loans payable fin cfPrior1YTDDuration1178242000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration523062000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration72510000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration643000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-91028000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-308318000JPY
Cash dividends paid fin cfPrior1YTDDuration-209886000JPY
Cash dividends paid fin cfCurrentYTDDuration-208898000JPY
Payments for acquisition of subsidiaries not resulting in change in scope of consolidation fin cfPrior1YTDDuration-601000JPY
Payments for acquisition of subsidiaries not resulting in change in scope of consolidation fin cfCurrentYTDDuration-596000JPY
Other net fin cfPrior1YTDDuration-25579000JPY
Other net fin cfCurrentYTDDuration59288000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration923657000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration707537000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration-1883000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration4095000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration527999000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-907650000JPY
Cash and cash equivalentsPrior2YearInstant10257778000JPY
Cash and cash equivalentsPrior1YearInstant11062021000JPY
Cash and cash equivalentsPrior1QuarterInstant10785778000JPY
Cash and cash equivalentsCurrentQuarterInstant10154370000JPY
Discounted trade notes receivablePrior1YearInstant25584000JPY
Discounted trade notes receivableCurrentQuarterInstant38227000JPY
Advertising expenses sgaPrior1YTDDuration418824000JPY
Advertising expenses sgaCurrentYTDDuration332036000JPY
Salaries and allowances sgaPrior1YTDDuration1188103000JPY
Salaries and allowances sgaCurrentYTDDuration1286923000JPY
Provision for bonuses sgaPrior1YTDDuration62219000JPY
Provision for bonuses sgaCurrentYTDDuration71956000JPY
Retirement benefit expenses sgaPrior1YTDDuration29224000JPY
Retirement benefit expenses sgaCurrentYTDDuration27387000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration16445000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration17397000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration1447000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration4773000JPY
Amortization of goodwill sgaPrior1YTDDuration78323000JPY
Amortization of goodwill sgaCurrentYTDDuration98296000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember7326508000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember1064101000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember2816517000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember697983000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember539688000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember12444800000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration12444800000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-08-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-08-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-09-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-09-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-09-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-09-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-09-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-08-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass